sponsored content October 15, 2024 SANYA, Hainan Island, China – Dr. Ashley Tuan, OD, PhD, the Chief Medical Officer of Visioneering Technologies,...
October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT...
May 6, 2024 SEATTLE, Wash. — Visioneering Technologies Inc. has shared the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for...
sponsored content April 3, 2024 In this interview, Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies Inc. (VTI) sat down...
sponsored content March 4, 2024 In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the...
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
sponsored content October 17, 2023 Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies...
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
sponsored content August 1, 2022 By Ashley Tuan, OD, PhD, FAAO Randomized controlled chicken studies have shown relative myopic defocus from a...
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
sponsored content March 15, 2022 Visioneering Technologies Inc. (VTI) has launched an international clinical trial that will test the efficacy of its...
January 24, 2022 ATLANTA — Visioneering Technologies Inc. announced that it has begun its international clinical trial that is designed to test...
November 4, 2021 BOSTON — During a press event at the American Academy of Optometry’s (AAO) 2021 meeting, Visioneering Technologies Inc. (VTI)...